Brief: Guardant Health Q1 Adjusted EPS USD -0.45 Vs. IBES Estimate USD -0.76
07/05/2026 21:05
May 07 (Reuters) - Guardant Health Q1 revenue USD 301.7 million vs. IBES estimate USD 279.2 million. Q1 adjusted net income USD -58.7 million vs. IBES estimate USD -94.9 million Q1 EPS USD -0.85 Q1 adjusted EBITDA USD -58.9 million vs. IBES estimate USD -47.7 million outlook FY revenue USD 1,300-1,320 million vs. IBES estimate USD 1,271 million
Recent news on Guardant Health
See all newsU.S. RESEARCH ROUNDUP-CF Industries, Kimberly-Clark, Welltower
U.S. RESEARCH ROUNDUP- Adobe, Caseys General Stores, Oracle
U.S. STOCKS ON THE MOVE-Intel, Victoria's Secret, Super Micro
U.S. STOCKS ON THE MOVE-Novo Nordisk, Intel, Oracle
U.S. STOCKS ON THE MOVE-Enliven Therapeutics, DXC Technology, Humacyte